KARRIE MCCOY: Open Payments
NPI 1487211397 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 30 payments from 10 companies in 2025. Trend: 2023 $611 · 2024 $648 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $328 |
| Viatris Specialty LLC | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Electromed, Inc. | 6 | $43 |
| ABBVIE INC. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Grifols USA, LLC | 1 | $29 |
| Verona Pharma, Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Philips North America LLC | 1 | $15 |
Products named: DUPIXENT, YUPELRI, BREZTRI, SMARTVEST, TEFLARO, PURIFIED CORTROPHIN GEL, Prolastin-C Liquid, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
